Gerard Criner, MD

Gerard Criner, MD, is chair and professor of thoracic medicine and surgery at Lewis Katz School of Medicine at Temple University and director of the Temple Lung Center.

Articles by Gerard Criner, MD

Pegtarazimod Reduces Supplemental Oxygen Need in Hospitalized AE-COPD Patients

ByGerard Criner, MD

June 9th 2026

Phase 2 findings presented at ATS 2026 by Gerald Criner, MD, show pegtarazimod cut supplemental oxygen needs in hospitalized AE-COPD patients for up to 60 days.

Mepolizumab Reduced COPD Exacerbations, With Gerard Criner, MD

ByGerard Criner, MD

May 19th 2026

At ATS 2026, pooled phase 3 data showed mepolizumab reduced COPD exacerbations and hospitalizations in patients with blood eosinophil counts starting at 150 cells/µL.

Rewriting Airway Disease With Trait-Based Care: 2025’s Convergence of Asthma and COPD Management

ByGerard Criner, MD,Linda Rogers, MD,Andrew (Truong-An) Ho, MD

December 1st 2025

Discover how precision medicine reshapes COPD treatment, focusing on inflammation and patient-specific traits for improved outcomes in airway diseases.

Going for GOLD: Updated COPD Guidelines with Gerard Criner, MD

ByAlbert Rizzo, MD,Gerard Criner, MD

May 29th 2025

Gerard Criner, MD, spells out GOLD improvements, from interventions like smoking cessation and pulmonary rehabilitation to the heightened importance of spirometry for diagnosis.

Mepolizumab Reduces Exacerbation Risk, Healthcare Resource Utilization in COPD

ByGerard Criner, MD

May 21st 2025

Gerard Criner, MD, reviews findings from a secondary analysis of the phase 3 MATINEE trial of mepolizumab and looks ahead to the potential significance of the drug, if approved.